TITLE

Infant HIV infection despite "universal" antenatal testing

AUTHOR(S)

Struik, S. S.; Tudor-Williams, G.; Taylor, G. P.; Portsmouth, S. D.; Foster, C. J.; Walsh, C.; Hanley, C.; Walters, S.; Smith, J. H.; Lyall, H.

PUB. DATE

January 2008

SOURCE

Archives of Disease in Childhood;Jan2008, Vol. 93 Issue 1, p59

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

We reviewed the antenatal HIV testing history, clinical presentation and outcome of 25 infants diagnosed with HIV between 1 January 2001 and 31 December 2005 in a tertiary referral hospital in London. Of the 25 cases, 21 had received antenatal care in the UK. Twelve mothers had not had an antenatal HIV test, four had tested positive antenatally, while five had had a negative HIV test on antenatal booking, implying seroconversion in pregnancy. When mothers had not been diagnosed antenatally, infants presented with severe infections, which were fatal in six cases. The majority (65%) of the children have long-term neurological sequelae. HIV seroconversion is an important cause of infant HIV in the UK.

ACCESSION #

31220816

 

Related Articles

• Testing for hepatitis B in pregnancy.  // New Zealand Doctor;5/18/2005, p24 

  Presents information on additional antenatal screening tests required for pregnant women with chronic hepatitis B. Test which confirms chronic infection; Need for pregnant women to be checked for hepatitis B replication; Significance of additional testing.

• To what extent could performance-based schemes help increase the effectiveness of prevention of mother-to-child transmission of HIV (PMTCT) programs in resource-limited settings? a summary of the published evidence. Touré, Hapsatou; Audibert, Martine; Dabis, François // BMC Public Health;2010, Vol. 10 Issue 1, p702 

  Background: In resource-limited settings, HIV/AIDS remains a serious threat to the social and physical well-being of women of childbearing age, pregnant women, mothers and infants. Discussion: In sub-Saharan African countries with high prevalence rates, pediatric HIV/AIDS acquired through...

• Opt in or opt out: What is optimal for prenatal screening for HIV infection? Walmsley, Sharon // CMAJ: Canadian Medical Association Journal;3/18/2003, Vol. 168 Issue 6, p707 

  Discusses how the use of antiretroviral therapy with elective cesarean section has decreased the risk of mother-to-child transmission of HIV. Importance of formula feeding; Cost-effectiveness of screenings; Rates of testing in the provinces of Canada; Consideration of the opt-in and opt-out...

• Evaluation of Universal Antenatal Screening for Group B Streptococcus. Van Dyke, Melissa K.; Phares, Christina R.; Lynfield, Ruth; Thomas, Ann R.; Arnold, Kathryn E.; Craig, Allen S.; Mohle-Boetani, Janet; Gershman, Ken; Schaffner, William; Petit, Susan; Zansky, Shelley M.; Morin, Craig A.; Spina, Nancy L.; Wymore, Kathryn; Harrison, Lee H.; Shutt, Kathleen A.; Bareta, Joseph; Bulens, Sandra N.; Zell, Elizabeth R.; Schuchat, Anne // New England Journal of Medicine;6/18/2009, Vol. 360 Issue 25, p2626 

  Background: Group B streptococcal disease is one of the most common infections in the first week after birth. In 2002, national guidelines recommended universal late antenatal screening of pregnant women for colonization with group B streptococcus to identify candidates for intrapartum...

• The detection of CMV in amniotic fluid and cervicovaginal smear samples by real-time PCR assay in prenatal diagnosis. Biri, Aydan; Bozdayı, Gülendam; Çiftçi, Banu; Dinç, Bedia; Yücel, Aysegül; Rota, Seyyal // Archives of Gynecology & Obstetrics;Feb2006, Vol. 273 Issue 5, p261 

  Objective: There is no specific antiviral therapy or a vaccine, which could be safely administered to the pregnant women with primary human cytomegalovirus (CMV) infection. Therefore, prenatal diagnosis has a critical role in the management of pregnancy, complicated by this disease. In this...

• Don't worry; get pregnant.  // Contemporary OB/GYN;Jul2004, Vol. 49 Issue 7, p21 

  The article presents the results of a study on the concerns during assisted reproductive technologies scale and pregnancy outcomes conducted by researchers from the University of California in San Diego. The study found that women who worried more about the medical aspects of the procedures had...

• Decrease of human immunodeficiency virus prevalence in antenatal clinics in Abidjan, Côte d'Ivoire, 1995–2002. Msellati, Philippe; Sakarovitch, Charlotte; Bequet, Laurence; Atta, Hubert; Alioum, Ahmadou; Viho, Ida; Timothée, Ouassa; Leroy, Valeriane; Welffens-Ekra, Christiane; Dabis, François // International Journal of STD & AIDS;Jan2006, Vol. 17 Issue 1, p57 

  Antenatal HIV seroprevalence surveys are important tools to understand the extent of the HIV epidemic in Africa. The main objective is to describe HIV prevalence trends from 1995–2002 in pregnant women consulting antenatal clinics in Abidjan, Côte d'Ivoire. We proposed HIV test to...

• Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: effect on testing rates. Jayaraman, Gayatri C.; Preiksaitis, Jutta K.; Larke, Bryce // CMAJ: Canadian Medical Association Journal;3/18/2003, Vol. 168 Issue 6, p679 

  Abstract Background Mandatory reporting of HIV infection to public health authorities, although now common, may deter people from undergoing testing. We examined HIV testing frequency in Alberta before and after mandatory reporting was implemented. We also examined the effect on testing rates...

• HIV Testing Among U.S. Women During Prenatal Care: Findings from the 2002 National Survey of Family Growth. Anderson, John E.; Sansom, Stephanie // Maternal & Child Health Journal;Sep2006, Vol. 10 Issue 5, p413 

  Objectives: To measure progress toward the US Public Health Service recommended goal that HIV screening be part of the routine battery of prenatal tests for all pregnant women, using data from a nationally-representative reproductive health survey. Methods: Data from the 2002 National Survey of...

Read the Article